CULLINAN ONCOLOGY
Cullinan Oncology is a developer of an externally sourced cancer therapeutics intended to end a drug program quickly if the early research suggests it won't work. The company's therapeutics are developed via assets sourced internally through dry lab or externally through business, academic and pharma collaborations, enabling researchers to get a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model.
CULLINAN ONCOLOGY
Social Links:
Industry:
Biopharma Biotechnology Medical Device
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.cullinanoncology.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
389.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Sesen Bio, Inc.
Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Prelude Therapeutics
Prelude Therapeutics is a developer of novel therapies intended to target key drivers of cancer cell growth, survival and resistance.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Foresite Capital
Foresite Capital investment in Series C - Cullinan Oncology
BVF Partners
BVF Partners investment in Series C - Cullinan Oncology
Nextech Invest
Nextech Invest investment in Series C - Cullinan Oncology
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series C - Cullinan Oncology
Schooner Capital
Schooner Capital investment in Series C - Cullinan Oncology
Eventide
Eventide investment in Series C - Cullinan Oncology
OrbiMed
OrbiMed investment in Series C - Cullinan Oncology
F2 Ventures
F2 Ventures investment in Series C - Cullinan Oncology
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series C - Cullinan Oncology
MPM Capital
MPM Capital investment in Series C - Cullinan Oncology
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2019-02-05 | Cullinan Pearl | Cullinan Oncology investment in Series A - Cullinan Pearl | N/A |
Key Employee Changes
Date | New article |
---|---|
2022-08-15 | Cullinan Oncology Announces Appointment of Jacquelyn Sumer as Chief Legal Officer |
2021-10-18 | Cullinan Oncology Appoints Nadim Ahmed as Chief Executive Officer |
Official Site Inspections
http://www.cullinanoncology.com Semrush global rank: 4.15 M Semrush visits lastest month: 2.87 K
- Host name: 21.104.215.35.bc.googleusercontent.com
- IP address: 35.215.104.21
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043